Credit Agricole’s Aurinia Pharmaceuticals AUPH Stock Holding History

Credit Agricole’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-57,103	Closed	-$1.39M	–	1427
2017 Q1	$1.39M	Buy	+57,103	New	+$264K	﹤0.01%	1097

Other funds holding AUPH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Credit Agricole's AUPH Position: Q2 2017 in Review

Credit Agricole sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2017, closing a stake of 57,103 shares — an estimated $1.39M sold.

Credit Agricole first reported a position in AUPH in Q1 2017 and held it in 1 quarter. The position peaked at $1.39M in Q1 2017. 65 funds tracked by Wall St. Rank hold AUPH as of Q2 2017.

Credit Agricole reported no remaining Aurinia Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
Credit Agricole sold 57,103 Aurinia Pharmaceuticals shares in Q2 2017, an estimated $1.39M.
Credit Agricole first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 1 quarter.
Credit Agricole's Aurinia Pharmaceuticals position peaked at $1.39M in Q1 2017.
65 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2017.

Based on Credit Agricole's 13F filing for Q2 2017, filed 14 Aug 2017.